A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.115010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Evan M Cale und 28 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: HIV Envelope Protein gp120, Polysaccharides, HIV-1, Antibodies, Neutralizing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- San Diego Biomedical Research Institute, San Diego, CA 92121, USA.
- Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: nicole.doriarose@nih.gov.
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicia…
- Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; ModeX Therapeutics, Weston, MA 02493, USA.
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Cale, E. M., Shen, C. H., Olia, A. S., Radakovich, N. A., Rawi, R., Yang, Y., Ambrozak, D. R., Bennici, A. K., Chuang, G. Y., Crooks, E. D., Driscoll, J. I., Lin, B. C., Louder, M. K., Madden, P. J., Messina, M. A., Osawa, K., Stewart-Jones, G. B. E., Verardi, R., Vrakas, Z., …, & Gorman, J. (2024). A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115010
Vancouver
Cale EM, Shen CH, Olia AS, Radakovich NA, Rawi R, Yang Y, et al. A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies. Cell Reports. 2024. doi:10.1016/j.celrep.2024.115010
BibTeX
@article{Cale2024,
author = {Cale, Evan M and Shen, Chen-Hsiang and Olia, Adam S and Radakovich, Nathan A and Rawi, Reda and Yang, Yongping and Ambrozak, David R and Bennici, Anthony K and Chuang, Gwo-Yu and Crooks, Emma D and Driscoll, Jefferson I and Lin, Bob C and Louder, Mark K and Madden, Patrick J and Messina, Michael A and Osawa, Keiko and Stewart-Jones, Guillaume B E and Verardi, Raffaello and Vrakas, Zoe and Xie, Danielle and Zhang, Baoshan and Binley, James M and Connors, Mark and Koup, Richard A and Pierson, Theodore C and Doria-Rose, Nicole A and Kwong, Peter D and Mascola, John R and Gorman, Jason},
title = {A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.115010}
}
EUVIMED